butylhydroxybutylnitrosamine has been researched along with Carcinoma, Intraepithelial in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batourina, E; Cordon-Cardo, C; Dan, H; Dunlop, M; Mansukhani, M; Mendelsohn, C; Molotkov, A; Oyon, D; Schneider, K; Van Batavia, J; Wu, XR; Yamany, T | 1 |
| Afonso, J; Arantes-Rodrigues, R; Colaço, A; Da Silva, VM; De La Cruz, LF; Lopes, C; Lourenço, L; Oliveira, PA; Santos, L; Sousa-Diniz, C | 1 |
| Evans, BJ; Fujii, N; Kotani, H; Mikami, Y; Nishiyama, H; Nishizawa, K; Ogawa, O; Oishi, S; Peiper, SC; Saito, R; Tanahara, N; Toda, Y; Watanabe, J | 1 |
| Hicks, RM | 1 |
| Babaya, K; Hirao, Y; Iwai, A; Matsuki, H; Nakatsuji, F; Okajima, E; Samma, S; Tabata, S; Uemura, H | 1 |
| Frolov, AG; Iogannsen, MG; Pliss, GB; Vlasov, NN | 1 |
| Fukushima, S; Lee, CC; Min, W; Salim, EI; Sukata, T; Wanibuchi, H; Yamamoto, S | 1 |
| Kunze, E; Schatt, S; Schauer, A | 1 |
| Fukushima, S; Kawabe, M; Mori, Y; Ni-I, H; Okada, M; Shirai, T; Tamano, S | 1 |
| Fukushima, S; Hagiwara, A; Okada, M; Shirai, T; Suzuki, E; Tamano, S | 1 |
| Fukushima, S; Kakizoe, T; Niijima, T; Nishio, Y; Ohtani, M; Sato, S; Sugimura, T | 1 |
1 review(s) available for butylhydroxybutylnitrosamine and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
The scientific basis for regarding vitamin A and its analogues as anti-carcinogenic agents.
Topics: Animals; Antineoplastic Agents; beta Carotene; Butylhydroxybutylnitrosamine; Carcinoma in Situ; Carcinoma, Papillary; Carotenoids; Cell Differentiation; Dose-Response Relationship, Drug; Epithelium; Fenretinide; Humans; Isotretinoin; Neoplasms; Neoplasms, Experimental; Tretinoin; Urinary Bladder Neoplasms; Vitamin A | 1983 |
10 other study(ies) available for butylhydroxybutylnitrosamine and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Bladder cancers arise from distinct urothelial sub-populations.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma in Situ; Carcinoma, Papillary; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Lineage; Female; Humans; Keratin-5; Luminescent Proteins; Male; Mice, 129 Strain; Mice, Knockout; Mice, Transgenic; Microscopy, Confocal; Neoplastic Stem Cells; Urinary Bladder Neoplasms | 2014 |
The effects of sirolimus on urothelial lesions chemically induced in ICR mice by BBN.
Topics: Animals; Antibiotics, Antineoplastic; Butylhydroxybutylnitrosamine; Carcinoma in Situ; Carcinoma, Papillary; Hyperplasia; Immunoenzyme Techniques; Male; Mice; Mice, Inbred ICR; Sirolimus; Urinary Bladder Neoplasms | 2009 |
Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4.
Topics: Animals; Blotting, Western; Butylhydroxybutylnitrosamine; Carcinoma in Situ; Diagnostic Imaging; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Peptide Fragments; Receptors, CXCR4; Spectrometry, Fluorescence; Tumor Cells, Cultured; Urinary Bladder; Urinary Bladder Neoplasms; Urine | 2010 |
Rapid induction of carcinoma in situ in dog urinary bladder by sequential treatment with N-methyl-N'-nitrosourea and N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma in Situ; Dogs; Drug Administration Schedule; Female; Methylnitrosourea; Nitrosamines; Nitrosourea Compounds; Time Factors; Urinary Bladder Neoplasms | 1984 |
[A model of rat's urinary bladder tumor induced by subcutaneous injection of N-butyl-N-(4-hydroxybutyl)-nitrosamine].
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma in Situ; Carcinoma, Transitional Cell; Disease Models, Animal; Glucuronidase; Papilloma; Rats; Urinary Bladder Neoplasms | 1998 |
Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogenicity Tests; Carcinogens; Carcinoma in Situ; Carcinoma, Transitional Cell; Cocarcinogenesis; Gene Deletion; Genes, p53; Genotype; Male; Mice; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Urinary Bladder Neoplasms | 1999 |
Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats.
Topics: Animals; Autoradiography; Butylhydroxybutylnitrosamine; Carcinoma in Situ; Carcinoma, Papillary; Carcinoma, Transitional Cell; Cell Transformation, Neoplastic; DNA, Neoplasm; Female; Hyperplasia; Neoplasms, Experimental; Nitrosamines; Precancerous Conditions; Rats; Urinary Bladder Neoplasms | 1976 |
Low susceptibility of nude mice to induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma in Situ; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Male; Mice; Mice, Nude; Nitrosamines; Urinary Bladder Neoplasms; Urodynamics | 1992 |
Time- and dose-dependent induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine in B6C3F1 mice.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma in Situ; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Dose-Response Relationship, Drug; Epithelium; Male; Mice; Mice, Inbred Strains; Neoplasm Invasiveness; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1991 |
Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma; Carcinoma in Situ; Epithelium; Female; Mice; Neoplasm Invasiveness; Nitrosamines; Urinary Bladder; Urinary Bladder Neoplasms | 1986 |